Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine | Zendy

Maura L. Furey | Zendy; Wayne C. Drevets | Zendy; Joanna Szczepanik | Zendy; Ashish Khanna | Zendy; Allison C. Nugent | Zendy; Carlos A. Zarate | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine

Author(s) -

Maura L. Furey,

Wayne C. Drevets,

Joanna Szczepanik,

Ashish Khanna,

Allison C. Nugent,

Carlos A. Zarate

Publication year - 2015

Publication title -

the international journal of neuropsychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 107

eISSN - 1469-5111

pISSN - 1461-1457

DOI - 10.1093/ijnp/pyv028

Subject(s) - antidepressant , neuroimaging , scopolamine , psychology , neuroscience , medicine , pharmacology , hippocampus

Faster acting antidepressants and biomarkers that predict treatment response are needed to facilitate the development of more effective treatments for patients with major depressive disorders. Here, we evaluate implicitly and explicitly processed emotional faces using neuroimaging to identify potential biomarkers of treatment response to the antimuscarinic, scopolamine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research